|
Published by: BCC Research
Published: Sep. 1, 2003 - 168 Pages
Table of Contents
Introduction
Medical Diagnostic Reagents, Chemicals, And Other Consumables
Study Background
Study Goals And Objectives
Intended Audience
Scope And Format
Methodology And Information Sources
Analyst Credentials
Related Bcc Research
Reports
Monthly Newsletter
Bcc On-Line Services
Executive Summary
Summary Table:
Total U.S. And Global Market For In-Vitro Diagnostic Chemicals, Carriers, And Consumables, Through 2008 ($ Billions)
Summary Figure:
Total U.S. And Global Market For In-Vitro Diagnostic Chemicals, Carriers, And Consumables, 2002-2008 ($ Billions)
Overview Of Diagnostic Chemicals, Carriers, And Other Consumables Market
Types Of Tests
Microbiological Analysis
Chemical Analysis
Immunological Analysis
Nucleic Acid Analysis
Types Of Products
Reagents
Microbiological Reagents
Table 1 Major Microbiological Reagents
Chemical Reagents
Table 2 Major Diagnostic Chemical Reagents
Immunological Reagents
Table 3 Major Diagnostic Immunological Reagents
Nucleic Acid Reagents
Table 4 Diagnostic Nucleic Acid Reagents
Other Chemicals
Functional Chemicals
Nonfunctional Chemicals
Disposable Device Carriers And Other Consumables
Applications And End-User Markets
Diagnostic Testing Applications
Infectious Disease Testing
Figure 1 U.S. Market For Infectious Disease Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Current Market
Figure 2 Percent Market Share For Diagnostic Tests For Infectious Diseases By Type Of Test, 2002 (%)
Table 5 U.S. Infectious Disease Testing Market By Product Type, 2002
Market Drivers
Epidemiological Trends
Table 6 U.S. Trends In Major Infectious Diseases, 1990 Through 2002 (Number Of New Cases Annually)
Table 7 Impact Of Epidemiological Trends On The Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Infectious Disease Testing, 2002-2008 ($ Millions)
Development And Commercialization Of New Diagnostic Techniques
Threat Of Bioterrorism
Projected Market
Table 8 Projected Demand For Infectious Disease Diagnostic Products, Through 2008 ($ Millions)
Cancer Testing
Figure 3 Market For Cancer Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Current Market
Figure 4 Diagnostic Tests For Cancer By Type Of Test, 2002 (Percent Of All Tests By Value)
Table 9 U.S. Cancer Testing Market By Product Type, 2002 ($ Billions)
Market Drivers
Demographic And Epidemiological Trends, 2002-2008
Table 10 Impact Of Demographic And Epidemiological Trends On The Market For Cancer Diagnostic Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Development And Commercialization Of New Diagnostic Techniques
Replacement Tests
New Applications
Hpv Screening For Cervical Cancer
Mammastatin Serum Assays For Breast Cancer Screening
Table 11 Impact Of New Technologies On Market For Cancer Diagnostic Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Projected Market
Table 12 Projected Demand For Cancer Diagnostic Products, Through 2008 ($ Millions)
Hormone Analysis
Figure 5 Market For Hormone Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Current Market
Figure 6 Hormone Tests By Type Of Test, 2002 (Percent Of All Tests By Value)
Table 13 U.S. Hormone Testing Market By Product Type, 2002 ($ Millions)
Market Drivers
Childbearing Trends
Table 14 U.S. Trends In Fertility And Childbearing, Through 2002
Increase In Older Age Groups
Table 15 Trends In Older Age Groups Of U.S. Population, Through 2002
Projected Market
Table 16 Impact Of Epidemiological Trends On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Hormone Testing, 2002-2008 ($ Millions)
Drug Testing
Figure 7 Market For Drug Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Current Market
Figure 8 Drug Tests By Type Of Test, 2002 (Percent Of All Tests By Value)
Table 17 U.S. Drug Testing Market By Product Type, 2002
Market Drivers
Legislation
Drug Abuse Rates
New Products And Testing Technologies
Growing Use Of Prescription Drugs
Projected Market
Table 18 Impact Of Demand Drivers On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Drug Testing, 2002-2008
Blood/Urine Testing
Table 19 Key Blood And Urine Chemistry Parameters
Table 19 (Continued)
Figure 9 Market For Blood And Urine Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Current Market
Table 20 U.S. Blood/Urine Testing Market By Product Type, 2002 ($ Millions)
Market Drivers
At-Risk Populations
Table 21 Incidence Of Diabetes Among Different Age Groups
Incidence Of Diabetes
New Products And Testing Technologies
Projected Market
Table 22 Impact Of Demand Drivers On The Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Blood/Urine Chemistry Testing, 2002-2008 ($ Millions)
Medical Research
Figure 10 Market Diagnostic Reagents, Chemicals, Carriers, And Other Consumables Used In Medical Research, Through 2008 ($ Millions)
Current Market
Table 23 U.S. Medical Research Testing Market By Product Type, 2002 ($ Millions)
Market Drivers And The National Institutes Of Health
Projected Market
Table 24 Impact Of Demand Drivers On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Medical Research, 2002-2008 ($ Millions)
Veterinary Medicine
Figure 11 Market For Veterinary Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Current Market
Table 25 U.S. Veterinary Testing Market By Product Type, 2002 ($ Millions)
Market Drivers
Commercial Livestock Trends
Table 26 Trends In U.S. Meat Production, Through 2002 (Billion Pounds)
Trends In Consumer Spending On Companion Animal Care
Table 27 Trends In U.S. Consumer Spending On Pet Care, Including Veterinary Services, Through 2002 ($ Billions)
Projected Market
Table 28 Impact Of Demand Drivers On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Veterinary Diagnostic Testing, 2002-2008 ($ Millions)
End-Use Markets
Clinical Laboratories
Figure 12 Number Of Clia-Registered Clinical Laboratories, 1993-2002
Figure 13 Total Clia-Registered Laboratories, By Type, 2002 (Percent Of Laboratories Reporting)
Figure 14 Diagnostic And Other Clinical Tests Carried Out By Type Of Laboratory, 2002 (Percent Of All Tests, By Value)
Medical Research Laboratories
Table 29 Entities Engaged In Medical Research
Veterinary Laboratories
Table 30 Entities Engaged In Veterinary Diagnostic Activities
Individual Consumers For Home-Use Market
Government Regulation
Food And Drug Administration
Premarket Clearance
Good Manufacturing Practices
Responsible Agencies
Center For Devices And Radiological Health
Center For Biologics Evaluation And Research
Centers For Medicare And Medicaid Services
State Governments
Not-For-Profit Organizations
College Of American Pathologists
American Medical Association
U.S. Department Of Agriculture
U.S. Market For Mdk Reagents And Other Components
Summary
Figure 15 Total U.S. Market For Diagnostic Chemicals, Carriers, And Consumables, 2000-2008 ($ Millions)
Detailed Market Estimates And Projections, 2000 - 2008
Market Projection Methodology And Data Sources
Market By Application
Table 31 U.S. Market For Diagnostic Chemicals And Other Consumables By Application Segment, Through 2008 ($ Millions)
Figure 16 Market Shares By Application Segment, 2003 And 2008 (Percent Of Total Sales)
Market By Product Type
Summary
Table 32 Trends In Overall Consumption Of Diagnostic Components By Type Of Product, Through 2008 ($ Millions)
Detailed Analysis
Reagents
Table 33 Trends In Overall Consumption Of Reagents, By Type Of Reagent, Through 2008 ($ Millions)
Table 34 Largest-Selling Reagents, 2002-2008 ($ Millions)
Microbiological Reagents
Table 35 U.S. Market For Pap Stains And Other Microbiological Reagents, Through 2008 ($ Millions)
Chemical Reagents
Table 36 Trends In U.S. Market For Chemical Reagents, Through 2008 ($ Millions)
Immunological Reagents
Table 37 Trends In The U.S. Market For Immunological Reagents, Through 2008 ($ Millions)
Nucleic Acid Reagents
Table 38 Trends In The U.S. Market For Nucleic Acid Reagents, Through 2008 ($ Millions)
Other Chemicals
Table 39 Trends In The U.S. Market For Other Chemicals, Through 2008 ($ Millions)
Device Carriers And Other Consumables
Table 40 Trends In The U.S. Market For Device Carriers And Other Consumables, Through 2008 ($ Millions)
Market By End-Use
Figure 17 Trends In Diagnostic Component End-User Segments, 2003 And 2008
Table 41 Diagnostic Component Sales By End-User Segment, Through 2008 ($ Millions)
Long-Term Outlook For The U.S. Market
Developments That Will Influence The Long-Term Market
Demographic And Epidemiological Trends
Technology Trends
Economic Trends
Governmental/Regulatory Trends
Trends In The Structure Of The Health-Care Industry
Long-Term Market Prospects
Industry Structure, Financial Performance, And Competition
Industry Structure
Summary
Figure 18 Total U.S. Shipments Of Diagnostic Chemicals, Carriers, And Other Consumables, 2002 (%)
Diagnostic Reagents And Chemicals
Domestic Production
Industry Structure
Table 42 U.S. In-Vitro Diagnostic Substance Manufacturers Classified By Size Of Establishment
Figure 19 In-Vitro Diagnostic Product Shipments By Size Of Establishment (Percent Of Total Manufacturers’ Shipments)
Table 43 U.S. In-Vitro Diagnostic Reagent Manufacturers, Classified By Principal Product
Foreign Trade
Table 44 Net U.S. Imports Of Pharmaceuticals And Medicines, 1997-2000 ($ Billions)
Table 45 Domestic Production And Net Imports Of In-Vitro Diagnostic Products, 2000-2003 ($ Billions)
Device Carriers And Consumables
Domestic Production
Industry Structure
Figure 20 U.S. In-Vitro Diagnostic Assay System Components Suppliers (Total Number Of Companies In Each Category)
Performance
Sales
Table 46 Selected Diagnostic Product Companies’ Sales Performance, Through 2002 ($ Millions)
Table 47 Company Size Vs. Sales Performance, Through 2002
Profitability
Table 48 Company Size Vs. Profitability, 2000-2002
Competition And Market Shares
Clinical And Research Market
Figure 21 U.S. Clinical And Research Diagnostic Component Market Leaders, 2002 (Percent Of Total Sales)
Table 49 Clinical And Research Diagnostic Component Vendors’ U.S. Sales, 2002
Veterinary Market
Figure 22 U.S. Veterinary Diagnostic Component Market Leaders, 2002 (Percent Of Total Sales)
Table 50 Veterinary Diagnostic Component Vendors’ U.S. Sales, 2002
Sales And Distribution
Figure 23 U.S. Distribution Channels For Diagnostic Components (Percent Of Total Sales Through Each Channel)
Trends In Ownership And Industry Structure
International Dimensions
Global Market Estimates And Projections, 2002 To 2008
Figure 24 Trends In The Global Market For Diagnostic Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Billions)
Long-Term Trends In Global Markets
Company Profiles
Diagnostic Reagents, Chemicals, And Kits
Abaxis, Inc.
Table 51 Abaxis, Inc. Selected Financial Data, Through 2002 ($ Millions)
Abbott Laboratories, Inc.
Table 52 Abbott Laboratories, Inc. Sales Of Diagnostic Products, Through 2002 ($ Millions)
Acon Laboratories, Inc.
Affymetrix, Inc.
Bayer Diagnostics
Beckman Coulter, Inc.
Table 53 Beckman Coulter, Inc. Selected Financial Data, Through 2002 ($ Millions)
Table 54 Beckman Coulter, Inc. Sales By Geographical Region, 2002
Becton Dickinson & Co.
Table 55 Becton Dickinson & Co. Clinical Laboratory Solutions Segment Revenues, Through 2002 ($ Millions)
Biocheck, Inc.
Biomedical Diagnostics, Llc
Cytyc Corp.
Table 56 Cytyc Corp. Selected Financial Data, Through 2002 ($ Millions)
Dade Behring
Table 57 Dade Behring Selected Financial Data, Through 2002 ($ Millions)
Diadexus
Genzyme Diagnostics
Hemagen Diagnostics, Inc.
Heska Corp.
Table 58 Heska Corp. Selected Financial Data, Through 2002 ($ Millions)
Idexx Laboratories, Inc.
Table 59 Idexx Laboratories, Inc. Selected Financial Data, Through 2002 ($ Millions)
Infectio Diagnostics, Inc.
Inova Diagnostics, Inc.
Ivax Diagnostics, Inc.
Table 60 Ivax Diagnostics, Inc. Selected Financial Data, Through 2002 ($ Millions)
Meridian Bioscience, Inc.
Table 61 Meridian Bioscience, Inc. Selected Financial Data, Through 2002 ($ Millions)
Micromedx
Myriad Genetic Laboratories, Inc.
New Horizons Diagnostics Corp.
Orasure Technologies, Inc.
Ortho-Clinical Diagnostics
Pharmacia
Quest Diagnostics, Inc.
Qiagen N.V.
Roche Diagnostics
Table 62 Roche Diagnostics Sales By Business Segment, 2002
Synbiotics Corp.
Table 63 Synbiotics Corp. Selected Financial Data, Through 2002 ($ Millions)
Vysis, Inc.
Worldwide Medical Corp.
Device Carriers
Diagnostic Laminations Engineering
Evergreen Scientific, Inc.
Excel Scientific, Inc.
Globe Scientific, Inc.
Integrated Biomedical Technology
Millenium Diagnostics, Ltd.
North American Biomedical
Schleicher & Schuell Bioscience
Virotek, Llc
Whatman, Plc
Appendix
Major Diagnostic Tests
Infectious Disease Tests
Bacterial Tests
Table 64 Common Types Of Bacterial Infectious Diseases And Associated Diagnostic Tests
Staphylococcus
Helicobacter Pylori
Chlamydia
Streptococcus
Treponema
Neisseria Gonorrhea
Borrelia
Escherichia
Shigella
Legionella
Fungal Tests
Table 65 Common Types Of Fungal Infectious Diseases And Associated Diagnostic Tests
Aspergillus
Blastomyces
Candida
Coccidomycosis
Cryptococcosis
Histoplasmosis
Sporotrichosis
Viral Tests
Table 66 Common Types Of Viral Diseases And Associated Diagnostic Tests
Cytomegalovirus
Epstein-Barr Virus
Hepatitis
Human Immunodeficiency Virus (Hiv)
Influenza
Paramyxovirus
Rubella
Varicella Zoster
Protozoan Tests
Table 67 Common Types Of Protozoal Infectious Diseases And Associated Diagnostic Tests
Cryptosporidiosis
Giardiasis
Amoebic Dysentery
Toxoplasmosis
Malaria
Trichomoniasis
Cancer Testing
Fda-Approved Tests
Table 68 Common Types Of Cancer And Associated Diagnostic Tests
Cervical Cancer Tests
Pap Smear
Human Papilloma Virus Test
Colorectal Cancer Tests
Fecal Occult Blood Test
Bladder Cancer Tests
Bladder Tumor Antigen Test
Nuclear Matrix Protein Test For Bladder Cancer
Genetic Markers For Bladder Cancer Test
Breast Cancer Tests
Ca (Cancer Antigen) 15-3 Test
Ca 27-29 (Truquant) Test
Estrogen And Progesterone Receptor Tests
Her-2/Neu Test
Central Nervous System
Neuron-Specific Enolase Test
Colorectal Cancer
Carcinoembryonic Antigen Test
Gastric/Pancreatic/Stomach Cancer
Ca 19-9 Test
Liver Cancer
Alpha-Fetoprotein Test
Metastatic Melanoma
S-100 Test
Multiple Myeloma
Nasophryngeal Cancer And Epstein-Barr Virus Antibodies Test
Ovarian Cancer
Ca-125 Test
Ca 72-4 Test
Prostate Cancer
Prostatic-Specific Antigen Test
Testicular Cancer
Human Chronic Gonadotropin Test
Thyroid Medullary Carcinoma
Calcitonin Test
New Tests
Genetic Test For Hpv
Genetic Test For Potential Recurrence Of Breast Cancer
Genetic Test For Colon Cancer
Genetic Test For Lung Cancer
List Of Tables
Summary Table:
Total U.S. And Global Market For In-Vitro Diagnostic Chemicals, Carriers, And Consumables, Through 2008 ($ Billions)
Table 1 Major Microbiological Reagents
Table 2 Major Diagnostic Chemical Reagents
Table 3 Major Diagnostic Immunological Reagents
Table 4 Diagnostic Nucleic Acid Reagents
Table 5 U.S. Infectious Disease Testing Market By Product Type, 2002
Table 6 U.S. Trends In Major Infectious Diseases, 1990 Through 2002 (Number Of New Cases Annually)
Table 7 Impact Of Epidemiological Trends On The Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Infectious Disease Testing, 2002-2008 ($ Millions)
Table 8 Projected Demand For Infectious Disease Diagnostic Products, Through 2008 ($ Millions)
Table 9 U.S. Cancer Testing Market By Product Type, 2002 ($ Billions)
Table 10 Impact Of Demographic And Epidemiological Trends On The Market For Cancer Diagnostic Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Table 11 Impact Of New Technologies On Market For Cancer Diagnostic Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Table 12 Projected Demand For Cancer Diagnostic Products, Through 2008 ($ Millions)
Table 13 U.S. Hormone Testing Market By Product Type, 2002 ($ Millions)
Table 14 U.S. Trends In Fertility And Childbearing, Through 2002
Table 15 Trends In Older Age Groups Of U.S. Population, Through 2002
Table 16 Impact Of Epidemiological Trends On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Hormone Testing, 2002-2008 ($ Millions)
Table 17 U.S. Drug Testing Market By Product Type, 2002
Table 18 Impact Of Demand Drivers On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Drug Testing, 2002-2008
Table 19 Key Blood And Urine Chemistry Parameters
Table 20 U.S. Blood/Urine Testing Market By Product Type, 2002 ($ Millions)
Table 21 Incidence Of Diabetes Among Different Age Groups
Table 22 Impact Of Demand Drivers On The Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Blood/Urine Chemistry Testing, 2002-2008 ($ Millions)
Table 23 U.S. Medical Research Testing Market By Product Type, 2002 ($ Millions)
Table 24 Impact Of Demand Drivers On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Medical Research, 2002-2008 ($ Millions)
Table 25 U.S. Veterinary Testing Market By Product Type, 2002 ($ Millions)
Table 26 Trends In U.S. Meat Production, Through 2002 (Billion Pounds)
Table 27 Trends In U.S. Consumer Spending On Pet Care, Including Veterinary Services, Through 2002 ($ Billions)
Table 28 Impact Of Demand Drivers On Market For Diagnostic Chemicals, Carriers, And Other Consumables Used In Veterinary Diagnostic Testing, 2002-2008 ($ Millions)
Table 29 Entities Engaged In Medical Research
Table 30 Entities Engaged In Veterinary Diagnostic Activities
Table 31 U.S. Market For Diagnostic Chemicals And Other Consumables By Application Segment, Through 2008 ($ Millions)
Table 32 Trends In Overall Consumption Of Diagnostic Components By Type Of Product, Through 2008 ($ Millions)
Table 33 Trends In Overall Consumption Of Reagents, By Type Of Reagent, Through 2008 ($ Millions)
Table 34 Largest-Selling Reagents, 2002-2008 ($ Millions)
Table 35 U.S. Market For Pap Stains And Other Microbiological Reagents, Through 2008 ($ Millions)
Table 36 Trends In U.S. Market For Chemical Reagents, Through 2008 ($ Millions)
Table 37 Trends In The U.S. Market For Immunological Reagents, Through 2008 ($ Millions)
Table 38 Trends In The U.S. Market For Nucleic Acid Reagents, Through 2008 ($ Millions)
Table 39 Trends In The U.S. Market For Other Chemicals, Through 2008 ($ Millions)
Table 40 Trends In The U.S. Market For Device Carriers And Other Consumables, Through 2008 ($ Millions)
Table 41 Diagnostic Component Sales By End-User Segment, Through 2008 ($ Millions)
Table 42 U.S. In-Vitro Diagnostic Substance Manufacturers Classified By Size Of Establishment
Table 43 U.S. In-Vitro Diagnostic Reagent Manufacturers, Classified By Principal Product
Table 44 Net U.S. Imports Of Pharmaceuticals And Medicines, 1997-2000 ($ Billions)
Table 45 Domestic Production And Net Imports Of In-Vitro Diagnostic Products, 2000-2003 ($ Billions)
Table 46 Selected Diagnostic Product Companies’ Sales Performance, Through 2002 ($ Millions)
Table 47 Company Size Vs. Sales Performance, Through 2002
Table 48 Company Size Vs. Profitability, 2000-2002
Table 49 Clinical And Research Diagnostic Component Vendors’ U.S. Sales, 2002
Table 50 Veterinary Diagnostic Component Vendors’ U.S. Sales, 2002
Table 51 Abaxis, Inc. Selected Financial Data, Through 2002 ($ Millions)
Table 52 Abbott Laboratories, Inc. Sales Of Diagnostic Products, Through 2002 ($ Millions)
Table 53 Beckman Coulter, Inc. Selected Financial Data, Through 2002 ($ Millions)
Table 54 Beckman Coulter, Inc. Sales By Geographical Region, 2002
Table 55 Becton Dickinson & Co. Clinical Laboratory Solutions Segment Revenues, Through 2002 ($ Millions)
Table 56 Cytyc Corp. Selected Financial Data, Through 2002 ($ Millions)
Table 57 Dade Behring Selected Financial Data, Through 2002 ($ Millions)
Table 58 Heska Corp. Selected Financial Data, Through 2002 ($ Millions)
Table 59 Idexx Laboratories, Inc. Selected Financial Data, Through 2002 ($ Millions)
Table 60 Ivax Diagnostics, Inc. Selected Financial Data, Through 2002 ($ Millions)
Table 61 Meridian Bioscience, Inc. Selected Financial Data, Through 2002 ($ Millions)
Table 62 Roche Diagnostics Sales By Business Segment, 2002
Table 63 Synbiotics Corp. Selected Financial Data, Through 2002 ($ Millions)
Table 64 Common Types Of Bacterial Infectious Diseases And Associated Diagnostic Tests
Table 65 Common Types Of Fungal Infectious Diseases And Associated Diagnostic Tests
Table 66 Common Types Of Viral Diseases And Associated Diagnostic Tests
Table 67 Common Types Of Protozoal Infectious Diseases And Associated Diagnostic Tests
Table 68 Common Types Of Cancer And Associated Diagnostic Tests
List Of Figures
Summary Figure:
Total U.S. And Global Market For In-Vitro Diagnostic Chemicals, Carriers, And Consumables, 2002-2008 ($ Billions)
Figure 1 U.S. Market For Infectious Disease Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Figure 2 Percent Market Share For Diagnostic Tests For Infectious Diseases By Type Of Test, 2002 (%)
Figure 3 Market For Cancer Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Figure 4 Diagnostic Tests For Cancer By Type Of Test, 2002 (Percent Of All Tests By Value)
Figure 5 Market For Hormone Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Figure 6 Hormone Tests By Type Of Test, 2002 (Percent Of All Tests By Value)
Figure 7 Market For Drug Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Figure 8 Drug Tests By Type Of Test, 2002 (Percent Of All Tests By Value)
Figure 9 Market For Blood And Urine Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Figure 10 Market Diagnostic Reagents, Chemicals, Carriers, And Other Consumables Used In Medical Research, Through 2008 ($ Millions)
Figure 11 Market For Veterinary Testing Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Millions)
Figure 12 Number Of Clia-Registered Clinical Laboratories, 1993-2002
Figure 13 Total Clia-Registered Laboratories, By Type, 2002 (Percent Of Laboratories Reporting)
Figure 14 Diagnostic And Other Clinical Tests Carried Out By Type Of Laboratory, 2002 (Percent Of All Tests, By Value)
Figure 15 Total U.S. Market For Diagnostic Chemicals, Carriers, And Consumables, 2000-2008 ($ Millions)
Figure 16 Market Shares By Application Segment, 2003 And 2008 (Percent Of Total Sales)
Figure 17 Trends In Diagnostic Component End-User Segments, 2003 And 2008
Figure 18 Total U.S. Shipments Of Diagnostic Chemicals, Carriers, And Other Consumables, 2002 (%)
Figure 19 In-Vitro Diagnostic Product Shipments By Size Of Establishment (Percent Of Total Manufacturers’ Shipments)
Figure 20 U.S. In-Vitro Diagnostic Assay System Components Suppliers (Total Number Of Companies In Each Category)
Figure 21 U.S. Clinical And Research Diagnostic Component Market Leaders, 2002 (Percent Of Total Sales)
Figure 22 U.S. Veterinary Diagnostic Component Market Leaders, 2002 (Percent Of Total Sales)
Figure 23 U.S. Distribution Channels For Diagnostic Components (Percent Of Total Sales Through Each Channel)
Figure 24 Trends In The Global Market For Diagnostic Reagents, Chemicals, Carriers, And Other Consumables, 2002-2008 ($ Billions)
Abstract Clinical and research laboratories, health-care providers, and manufacturers of single-use medical diagnostic kits (MDKs) in the United States consume $6.8 billion per year of in-vitro reagents, chemicals, and other consumables in order to evaluate individuals' overall health and diagnose, treat, and monitor disease. This study focuses on the resulting market for:
· Reagents and other active substances that are used to interact with sample substances to produce a reaction that can be measured and/or seen.
· Nonactive ingredients that are added to or used in conjunction with the reagents to enhance their manufacturability, performance, and/or preservation (e.g., surfactants, polymers, functional materials, biocides, and preservatives).
· Consumable or single-use devices and containers, such as vials, cards, slides, films, filters, membranes, and trays-integrals parts of the tests carried out using the reagents.
The study does not cover:
· Reagents and other substances used in in-vivo testing.
· Laboratory or analytical devices, such as centrifuges and spectrometers.
· Reusable laboratory ware, such as glass beakers and test tubes.
· Packaging materials.
STUDY BACKGROUND
In recent years, there have been dramatic changes in the diagnostic market. The range of conditions that can be tested for has greatly expanded as well as the variety of analytical techniques employed. Other major trends in the diagnostic industry have been the rapid growth of the at-home testing market (including both greater use of established types of tests and the addition of new tests, such as cholesterol measurements) at the expense of the laboratory testing market, and the expansion of the medical research market segment. An additional trend that has influenced the diagnostic market has been the development of inexpensive, automated testing devices known as point-of-care (POC) instruments, which have replaced single-use diagnostic kits in smaller laboratories and physicians' offices. Recognizing the changes that have occurred in the diagnostic market, Business Communications Co. (BCC) published an in-depth analysis of the medical diagnostic kit (MDK) industry and market in 2002, C-045X, Medical Diagnostic Kits.
STUDY GOALS AND OBJECTIVES
This study is intended to complement C-045X, Medical Diagnostic Kits by analyzing the implications of the changing medical diagnostic market for diagnostic reagents, chemicals, and other consumables in MDKs, as well as in traditional laboratory, clinic, and physicians' office settings. It analyzes U.S. and global markets for these products in the light of the most recent available information. In addition to looking at current and future markets for reagents, chemicals, and other consumables, the study analyzes technological, economic, and regulatory developments that may have a long-term impact on the size and structure of the market
This report provides an analysis of the market for diagnostic reagents, chemicals, and other consumables by application (e.g., infectious diseases, cancer), product type (e.g., type of reagent) and target market (e.g., consumer market or research laboratories). Future market trends are analyzed with consumption forecasts for specific market segments.
More specific objectives are to:
· Identify and segment the main types of reagents, chemicals, and other consumables that have been commercialized to date.
· Analyze the historical and current value of shipments of each of these product segments in specified applications and end-user markets.
· Identify and evaluate the impact of demographic, technological, regulatory, and other factors that will drive future demand in each of these segments.
· Forecast the value of future shipments in each segment.
· Identify promising new diagnostic technologies and products still in the development and testing stage, and assess the probability that they will be commercialized successfully in the next 5 years.
· Identify leading suppliers of reagents, chemicals, and other consumables, and analyze industry structure (e.g., market shares, concentration, recent M&A activity).
· Assess the long-term outlook for diagnostic reagents, chemicals, and other consumables, taking into account market opportunities as well as technological, financial, and economic factors.
INTENDED AUDIENCE
The report has been written for the entire medical and health-care interest community, but is tailored especially for readers with an interest in the marketing and management dimensions of reagents, chemicals, and other consumables used in diagnostic testing procedures, such as:
· manufacturers and distributors of pharmaceuticals and biochemicals
· manufacturers and distributors of disposable and single-use laboratoryware
· investors
· the financial and analyst community
SCOPE AND FORMAT
This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the market for in-vitro diagnostic reagents, other chemical components, and other consumables used in performing diagnostic tests, such as device carriers. It does not include:
· laboratory and analytical devices and equipment
· multiple-use diagnostic devices and equipment, such as laboratory devices and reusable glassware
· shipping containers, packaging, or instructional materials
The study includes reagents, chemicals, carriers, and other consumables sold at arm's length, as well as components produced by integrated manufacturers for incorporation into diagnostic kits and systems. In such cases, the market reflects only the estimated value of the chemicals and other components, and not the additional value added by producing and selling the kit or system.
The study focuses primarily on the U.S. market, with a section discussing international markets for diagnostic chemicals and other consumables on a more general level of detail. Other sections of the report cover the following topics:
· major product types and applications, both commercial and developmental
· U.S. market size and segmentation, including historical data on sales by application, product type, and end-user group
· market drivers and constraints
· detailed U.S. market projections through 2008
· industry structure, competition, and market shares
· factors that may influence the long-term market for diagnostic reagents, chemicals, and consumables
METHODOLOGY AND INFORMATION SOURCES
The findings and conclusions of this report are based on information gathered from manufacturers and distributors of diagnostic reagents, chemicals, and other consumables, as well as manufacturers of related devices (e.g., medical diagnostic kits), laboratories, and other end users. Interview data were combined with information gathered through an extensive review of secondary sources, such as trade publications, trade associations, company literature, and online databases to produce the baseline market estimates contained in this report.
The base year for analyses and projections is 2002. At the time this report was prepared, year-end data for 2002 were not yet universally available. Where necessary, market estimates for 2002 were developed using interim (partial) data for 2002 combined with historical data for the years 1999 to 2001.
With 2002 as a baseline, market projections were developed for 2003 to 2008. These projections are based on a consensus among the primary contacts combined with our understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in Detailed Market Projections. All dollar projections presented in this report are in 2002 constant dollars.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
